Acta Clin Belg . Euglycemic Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and SARS-CoV-2 Pneumonia: Case Report and Review of the Literature

[tetano]

Acta Clin Belg


. 2020 Jun 16;1-5.
doi: 10.1080/17843286.2020.1780390. Online ahead of print.
Euglycemic Diabetic Ketoacidosis in a Patient With Type 1 Diabetes and SARS-CoV-2 Pneumonia: Case Report and Review of the Literature


Philippe Oriot ¹ , Michel P Hermans ²



Affiliations

• PMID: 32544373
• DOI: 10.1080/17843286.2020.1780390

Abstract

Objective: Recent publications on Coronavirus Disease-2019 (COVID-19) report that diabetic people with or without co-morbidities are at higher risk of developing severe and/or fatal illnesses.
Method and result: We report the first case of a 60-year-old man with a 27-year history of type 1 diabetes mellitus, infected by SARS-CoV-2 presenting with an euglycaemic ketoacidosis and an acute respiratory distress syndrome.
Conclusion: This case report reminds us of the importance of adjusting more recent glucose-lowering drugs, including sodium-glucose cotransporter 2 inhibitors, in the overall management of type 1 diabetic individuals during the ongoing COVID-19 outbreak.
Abbreviations: COVID-19: Coronavirus disease 2019 (SARS-CoV-2) virus, T1DM: Type 1 diabetes mellitus, T2DM: Type 2 diabetes mellitus, SGLT2i: Sodium-glucose cotransporter 2 inhibitor, DKA: diabetic ketoacidosis, euDKA: euglycaemic diabetic ketoacidosis.

Keywords: COVID-19; SARS-CoV-2; SGLT2i; euDKA; euglycaemic diabetic ketoacidosis; type 1 diabetes mellitus.